A defining characteristic of superantigens is their ability to stimulate T cells based predominantly on the type of variable segment of the T cell receptor (TCK) B chain (V3). The VB specificity of these toxins most likely results from direct contact between the toxin and the TCR, although the low affinity nature of this binding has prevented direct assessment of this interaction. To identify important functional sites on the toxin, we created chimeric enterotoxin genes between staphylococcal enterotoxins A and E (SEA and SEE) and tested the VB specificity of the chimeric toxins. This approach allowed us to identify three amino acid residues in the extreme COOH terminus of these toxins that are largely responsible for their ability to stimulate either human VB5-or VB8-bearing T cells, or mouse V~3 or VBll. We also found that residues in the NH2 terminus were required for wild-type levels of VB-specific T cell activation, suggesting that the NH2 and COOH ends of these superantigens may come together to form the full TCR V/~ contact site. SEA and SEE also differ with respect to their class II binding characteristics. Using the same chimeric molecules, we demonstrate that the first third of the molecule controls the class II binding phenotype. These data lead us to propose that for SEA and SEE, and perhaps for all bacterial-derived superantigens, the COOH and NH2 termini together form the contact sites for the TCR and therefore largely determine the V~ specificity of the toxin, while the NH2 terminus alone binds major histocompatibility complex class II molecules. The predominant role of the COOH terminus of bacterial superantigens in determining VB specificity resembles current models being proposed for vitally encoded superantigens, suggesting that these molecules may demonstrate some structural relationship not seen at the amino acid level.
Summary
A defining characteristic of superantigens is their ability to stimulate T cells based predominantly on the type of variable segment of the T cell receptor (TCK) B chain (V3). The VB specificity of these toxins most likely results from direct contact between the toxin and the TCR, although the low affinity nature of this binding has prevented direct assessment of this interaction. To identify important functional sites on the toxin, we created chimeric enterotoxin genes between staphylococcal enterotoxins A and E (SEA and SEE) and tested the VB specificity of the chimeric toxins. This approach allowed us to identify three amino acid residues in the extreme COOH terminus of these toxins that are largely responsible for their ability to stimulate either human VB5-or VB8-bearing T cells, or mouse V~3 or VBll. We also found that residues in the NH2 terminus were required for wild-type levels of VB-specific T cell activation, suggesting that the NH2 and COOH ends of these superantigens may come together to form the full TCR V/~ contact site. SEA and SEE also differ with respect to their class II binding characteristics. Using the same chimeric molecules, we demonstrate that the first third of the molecule controls the class II binding phenotype. These data lead us to propose that for SEA and SEE, and perhaps for all bacterial-derived superantigens, the COOH and NH2 termini together form the contact sites for the TCR and therefore largely determine the V~ specificity of the toxin, while the NH2 terminus alone binds major histocompatibility complex class II molecules. The predominant role of the COOH terminus of bacterial superantigens in determining VB specificity resembles current models being proposed for vitally encoded superantigens, suggesting that these molecules may demonstrate some structural relationship not seen at the amino acid level.
S
uperantigens are a family of T cell mitogens that are unique in two respects: first, they require the presence of MHC class II molecules to effectively activate T cells; and second, the T cells that respond to them share one or a few variable segments of the TCR VB chain (1) (2) (3) (4) (5) (6) . One class of proteins that demonstrates such characteristics are exotoxins derived from Staphylococcus aureus and Streptococcus pyogenes (staphylococcal enterotoxin [SE] 1 A through E, toxic shock toxin [TSST-1], and streptococcal pyrogenic exotoxins A and C). A second superantigen family consists of the proteins encoded by the 3' LTR of mouse mammary tumor viruses (MMTVs). Superantigen activation of T cells in a VB-specific manner, with only limited regard for the make up of the other variable segments of the TCR (D~, J~/, Vcr Joe), has been presumed to be due to direct contact between the toxin and the TCR VB chain. Indeed, the contact site on TCRs by bac-1 Abbreviations used in this paper: GAM, goat anti-mouse; SE, staphylococcal enterotoxin; SOE, splicing by overlap extension.
terial and viral superantigens has been mapped and shown to lie outside the site of the TCR thought to contact conventional peptide antigen/MHC complexes (7, 8) . Several years ago we and others demonstrated direct binding between bacterial superantigens and MHC class II molecules (9) (10) (11) . This binding reaction is of moderately high affinity, especially with SEA and HLA-DR, making it a relatively easy interaction to study functionally and map biochemically (12) . However, direct binding between toxins and TCRs has been much more difficult to demonstrate. This reaction, therefore, must be of lower affinity and/or more transient, although direct binding between bacterial superantigen/class II complexes and isolated TCR /3 chains has been reported (13) . As our mechanistic understanding of toxin-mediated T cell activation has increased, it is easy to understand why previous approaches of looking for mitogenic fragments of these molecules failed to provide convincing results. T cell activation by superantigens requires both class II binding and the TCR contact site on the same molecule. Therefore, a reductionist approach, finding smaller and smaller mitogenic fragments, is precluded in analysis of SE-mediated T cell activation, unless a single fragment were to possess both activities.
Besides the in vitro activities most often studied, such as T cell proliferation, VB-specific T cell activation, and MHC class II binding, the SEs and TSST-1 cause a number of in vivo effects, such as fever production (14) , emesis (15) , and toxic shock (16, 17) , that may reflect one or several of these in vitro activities. Consequently, it would be of substantial interest to construct mutant SEs that completely lacked, for example, the ability to activate T cells yet retained the ability to bind class II molecules and then test for the correlative loss of in vivo activities. To construct such mutations, one first must map the regions of the toxin that directly mediate these in vitro activities and then create discrete mutations that effectively eliminate one activity while preserving others.
Recently, Kappler et al. (18) advanced a structure-function model of the related enterotoxin SEB. Using a random mutagenesis approach, these investigators reported that mutations affecting both MHC class II binding and TCR. interaction/activation clustered to the NH2 terminus of the molecule. These data led them to propose that these two critical immunological functions are intertwined at the NH2-terminal end of the molecule. If this model is correct then hopes of constructing mutants with selective loss of one of these functions may be misfounded. However, previous data from our laboratory had suggested that class II binding and TCR contact activities were dissociable (19, 20) . Therefore, we sought to map these two activities using a different genetic approach to determine whether they are indeed intertwined or not.
To map functional regions of bacterial superantigens, we took the approach of constructing intragenic SEA/SEE chimeras. SEA and SEE, despite their high degree of structural similarity (21, 22) , demonstrate reciprocal patterns of VB-specific T cell activation (23) , as well as distinct class II binding a~nities (24, 25) , making them good candidates for this type of study. By testing the chimeric molecules for V:/ specificity, or class II binding a~nity, we hoped to localize the region of one or both molecules that mediates these functions. In this report, we use this approach to map the region of SEA and SEE that controls their VB specificity, and to separate this region from that determining class II binding af~nity.
Materials and Methods
Mice. 8-12-wk-old male B10.BR/SgSnJ mice were obtained from The Jackson Laboratory (Bar Harbor, ME). T cells were purified from spleen cells by lysis of RBC and adsorption of B cells onto goat anti-mouse (GAM) Ig--coated magnetic beads (Advanced Magnetics, Cambridge, MA) as described (20) . Purified T cells (2 x l@/ml) were stimulated with recombinant toxins and irradiated (2,000 rad) syngeneic spleen cells (106/ml) for 4 d. Viable nonadherent cells were isolated by lympholyte-M gradients, washed in HBSS, and analyzed by flow cytometry with a panel of FITClabeled, VB-specific mAbs (Pharmingen, San Diego, CA). Forward angle and 90 ~ light-scatter patterns were used to restrict the analysis to blast cells.
Antibodies. The following murine mAbs were used for isola- (26, 27) . The coding regions of the entA (SEA) and entE (SEE) genes were subcloned from the plasmids pMJB117 (22) and pMJB46 (21) , respectively, into the phagmid vector pBluescript II SK(-); these plasmids were designated pMV2 and pMV5, respectively (20) . All oligonudeotide primers were obtained form Midland Certified Reagent Co. (Midland, TX). To construct a chimeric enterotoxin gene, internal PCR primers were designed to provide at least 12 bp of priming homology on the two different toxin genes and ",,15 bp of overlapping homology with each other. The two fragments of the genes were amplified using the SOE primers and flanking primers homologous to the reverse primer (sense orientation) and M13-20 primer (antisense orientation) sites on the pBluescript vector. Primary PCR reactions consisted of 1 #M of each primer, 1 #g of template plasmid, 10/~1 of 10x PCR. buffer, 200 #M of each dNTP in a total volume of 100/~1. For the first several chimeras, 2.5 U Taq polymerase (Perkin-Elmer Cetus Corp., Norwalk, CT) was used along with the 10x buffer (Perkin-Elmer Cetus Corp.) with a final Mg 2 § concentration of 2.5 mM. For the remaining chimeras, 2.5 U of PFU polymerase (Stratagene, La Jolla, CA) per reaction was used with 10/~1 of the manufacturer's 10 x buffer no.
2 (200 mM Tris-C1, pH 8.8, 100 mM KC1, 60 mM [NH412SO4, 15 mM MgC12, and 1% triton X-100), as PFU polymerase was found to introduce far fewer polymerase errors than Taq polymerase. PCR. reactions were overlayed with 100 #1 light white mineral oil and denatured at 95~ for 5 rain, the polymerase was then added, and reactions were subjected to 27 cycles of amplification (1 min at 95~ 2 min at 55~ and 3 min at 72~ on a thermocycler (Perkin-Elmer Cetus Corp.). The products of the primary PCR reaction were separated on a 1.0% agarose gel, and the amplified products excised from the gel and melted in three volumes of 6 M NaI, 100 mM NaPO4, 22.2 mM dithiothreitol, pH 6.0. The DNA was isolated from melted agarose on SpinBind cartridges (FMC Bioproducts, Rockland, ME) according to the manufacturer's instructions. TypicaLly, two cartridges were used to purify the products from one PCR reaction. Each cartridge was eluted with 60/~1 of water, the eluates from the same reaction were pooled, and the DNA was precipitated with 0.1 vol of 3 M sodium acetate and 2.5 vol ethanol. The toxin fragments were resuspended in 20 #1 of water and quantitated at OD260. In the secondary PCR reaction, 1/~g of each of the toxin fragments to be spliced together were mixed in a 100-/~1 PCR reaction along with 1 #M of reverse primer and M13-20 primer each, 200 #M of each dNTP, 10 ~1 of 10x buffer, 2.5 U of polymerase, and subjected to 32 amplification cycles as described above except that the annealing temperature was lowered to 45~ The products of the secondary PCR reaction were phenol extracted, ethanol precipitated, and resolubilized in 32/~1 of water, supplemented with 4 ~1 of appropriate 10 x enzyme buffer, and digested with 40 U (4/~1) of either BamHI or HindlII (Gibco BRL, Gaithersburg, MD). Digestions were carried out for 2 h at 37~ with phenol extraction and ethanol precipi-tation between digestions. After completion of the second restriction digestion, the products were separated on a 1.0% agarose gel, and the band corresponding to the spliced and digested product was excised from the gel. This product could be distinguished from the predigested material on the basis of size because of the absence of the flanking DNA fragments. The digested fragment was purified from the agarose gel on one SpinBind cartridge, eluted in 80/~1 of water, and ethanol precipitated. The fragment was resolubilized in 15/~1 of water, quantitated at OD~0, and ligated into a BamHIHindlII-digested pBluescript II SK(-) vector at a 10:1 insert-tovector ratio. 0.5-5/~1 of the ligation reaction was used to transform XL-1 blue-competent cells (200236; Stratagene) according to the manufacturer's instructions. White colonies were screened for appropriate insert and orientation by bacterial PCR reactions (28) using the flanking primers (reverse and M13-20 primer), as well as one of the internal SOE primers used to construct the chimera. Clones displaying PCR products of appropriate size were chosen for further analysis. All of the chimeric/mutant toxins were sequenced in full and found to have no unintended mutations, or rarely, silent mutations. DNA sequencing was carried out on singlestranded templates using a Sequenase dideoxy termination sequencing kit (U.S. Biochemical Corp., Cleveland, OH) as previously described (20, 29) .
Nomenclature. Three types of recombinant toxins were made:
chimeric enterotoxin, region-specific exchange mutants, and point mutations. Chimeric enterotoxins were designated according to the composition of the NH2-and COOH-terminal regions followed by the amino acids at the chimeric junction; e. 
Production of the Ckimeric and Mutant Toxins. 2 liters of2x YT
media (16 g tryptone, 10 g yeast extract, and 5 g NaC1 per liter) containing 100 #g/ml ampicillin was inoculated with 75 ml of confluent overnight bacterial cultures. The cultures were grown to an OD600 of 0.9 and supplemented with isopropyl-B-Dthiogalactopyranoside (Pierce Chemical Co., Rockford, IL) to a final concentration of I mM. The cultures were returned to the incubator and grown with vigorous aeration for 2-4 h. At the end of the incubation period bacteria were pelleted at 4,000 rpm for 20 min at 4~ and resuspended in 20 ml of ice-cold SET (20% sucrose, 1 mM EDTA, and 20 mM Tris-C1, pH 7.5). The resuspended bacteria were incubated at 4~ for 15 min, pelleted at 4,800 rpm in a rotor (SS34; Sorvall, Wilmington, DE) and resuspended in 10 ml of 1 mM EDTA, rocked at 4~ for 45 rain, and repelleted at 7,000 rpm for 15 min. The supernatant, hereafter referred to as the shockate, was removed and filtered (0.45/zm). For toxins consisting mostly of SEA-derived sequences, the shockate was diluted 1:2 in PBS, pH 7.2, and purified on an anti-SEA Sepharose column as previously described (20) . For chimeric/mutant toxins consisting mostly of SEE-derived sequences, the shockate was concentrated to 1.5 ml, first on a Centriprep 10 and then on a Centricon 10 (Amicon Corp., Danvers, MA). The sample was ffactionated on a Superdex 75 gel filtration column in 200 mM ammonium bicarbonate using an FPLC system (Pharmacia LKB Biotechnology, Piscataway, NJ). The column was calibrated with native SEA to determine the fractions that would contain the ehting chimeric toxin. The semipurified toxin was concentrated to 3 ml on a Centricon 10 and desalted into PBS on a DG-10 column (BioPad Laboratories, Richmond, CA) according to the manufacturer's instructions. Total protein content was determined by the bicinchoninic acid assay (BCA) (Pierce Chemical Co.). Toxins prepared by affinity chromatography ran as single bands at 28 kD on Coomassie blue-stained SDS-PAGE gels. Typical yield from 1 liter broth (10 ml periplasmic shockate) was "~100 #g.
V~ Analysis of Toxin-activated Human T Cells. PBMC were obtained from freshly isolated buffy coat packs derived from healthy donors (Gulf Coast Blood Center, Houston, TX). T cells were purified from the PBMC by negative selection using GAM Ig--conjugated magnetic beads (Advanced Magnetics). Briefly, PBMC were stained with a cocktail of anti-class II and anti-monocyte mAb consisting ofL227, L243, 9.3F10, OKMI, and LM2/1.6.11 for 30 min at 4~ The cells were washed once and incubated with GAM Ig magnetic beads at a ratio of 200 x 10 ~ cells/12-ml equivalents of GAM Ig beads. The GAM Ig beads were washed four times in HBSS/2%FCS before use. The cells and beads were incubated for at least 2 h with gentle agitation at 4~ After one round of negative selection, the cells typically consisted of >96% CD3 + cells. Purified T cells (106/ml) and autologuus irradiated (1,000 tad) unfractionated PBMC (2.5 x 106/ml) were cultured in 5 ml of assay media composed of RPMI, 10% heat-inactivated human AB § serum, 100/zg/ml gentamicin, 1% antibiotic-antimycotic mixture, 2 mM t-glutamine, 5 mM Hepes (all components, except serum, from Gibco Laboratories, Grand Island, NY) in six-well dishes (3506; Costar, Cambridge, MA). All affinity-purified recombinant toxins were added to a final concentration of 0.5/~g/ml and the gel filtration-purified recombinant toxins were used at a final concentration of 5/~g/ml (found to be optimal for each of the preparations in preliminary experiments). Native SEA and SEE (Toxin Technology, Sarasota, FL) were added at a final concentration of 0.5 and 0.25/~g/ml, respectively. The cultures were incubated for 3 d at 37~ in a humidified incubator with 5% CO2. Viable cells were then isolated from the culture on an isolymph gradient and recultured in 5 ml of assay media supplemented with 18 ng/ml rib2 (R&D Systems, Minneapolis, MN) or 50 U/ml rlL-2 (Amgen Biologicals) overnight. The following day, 0.5 x 1@ cells were stained with either the indicated anti-V/~ antibody (T cell Diagnostics) followed by GAM Ig(G, Class II Binding Assay. The ability of selected chimeric toxins to bind MHC class II molecules directly was assessed using an HLADKl-transfected fibroblast cell line, D.5-3.1 (kindly provided by E. Long, National Institutes of Health, Bethesda, MD). The assay was performed essentially as described (19) , except the assay was carried out in HBSS/2% FCS and the cells were stained with a pretitered amount of SEA-FITC. 
Results

V/~ Specificity of SEA and SEE Maps to the COOH-terminal
Half of the Molecules. Previous results from our laboratory showed that the central disulfide loop region, highly conserved among the enterotoxins, plays an important role in their mitogenicity (19) , but does not itself contain the VB contact site (20) . Therefore, we began by constructing two chimeric molecules that were designed to localize the region determining the VB specificity of these two enterotoxins to one side of the loop region. Both of these chimeras were designed with SEE sequences at the NH2-terminal portion and SEA sequences at the COOH-terminal portion. The chimeric junctions were chosen to be well upstream and downstream of the cysteine loop, which in SEA is formed by cysteines 96 and 106. Analysis of the V~ specificity of these two chimeras indicated that they both closely resembled the stimulatory phenotype of SEA (Fig. 1) . Thus, the region of the molecule responsible for VB spedfidty mapped to the COOH-terminal half of these molecules, downstream of amino acid 123. Interestingly, T cell responses to these chimeras exhibited slightly lower levels of V/~5 and slightly elevated levels of VB8 compared with responses to native SEA. To define more precisely the region of the toxins that mediates VB specificity, we created a series of chimeric toxins in which the junction lay progressively further downstream from the 122-123 junction. These were constructed in the opposite orientation from the initial two to take advantages of the high V(38 signal of SEE. For chimeric toxins containing progressively fewer SEE sequences at the COOH terminus, the percentage of VB8 + T cell blasts decreased while that of Vfl5 + T cells increased (Fig. 2 A) . Some chimeric toxins showed an unexpected phenotype, stimulating significant levels of both Vfl5 + and Vfl8 + T cells. The most striking example of this was the chimera SEA-SEE 187-188, although it was also seen with SEA-SEE 162-163 and to a lesser degree with SEA-SEE 142-143. T cell blasts stimulated with SEA-SEE 187-188 contained approximately equal percentage of V35-and Vfl8-bearing T cells, although both levels were below those seen with wild-type SEA and SEE, respectively. As in the two chimeras shown in Fig. 1 , although the COOH terminus largely dictated the V3 specificity of chimeras SEA-SEE 142-143 and 160-161, the percentage of the V~8 + blasts was '~50% that of native SEE. As expected, the reciprocal constructs of these two chimeras stimulated predominantly V35 + T cells (Fig. 2 B) , confirming the importance of the COOH terminus in VB specificity. However, when the SEA-SEE chimeric junction was placed at amino acids 219-220, the chimera was phenotypically indistinguishable from native SEA. Because the 160-161 chimera possessed the most downstream junction that provided a clean reciprocally stimulating phenotype, we concluded that the region largely responsible for determining V3 specificity of these two toxins lay downstream of amino acid 161 and upstream of 219. Fig. 3 shows an amino acid comparison between SEA and SEE in the COOHterminal half of the molecule. Amino acid differences cluster to four regions, which we designated regions 1-4. Because regions 1-3 contained the greatest number of differences, we initially exchanged these regions between the two toxins to test the contribution of each to VB specificity independently of the other regions. Exchanging region 1, 2, or 3 from SEA into SEE or the reciprocal constructions showed no pertur- bation of the VB stimulatory phenotype compared to the native toxin (Table 1 ). The one exception was SEA-SEE(136-149), which stimulated Vfl8 + T cells significantly above background, although this increased stimulation of Vfl8 + T cells was not accompanied by a concomitant decrease in VB5 stimulation. Moreover, this mixed phenotype was not observed with the reciprocal construct SEE-SEA(136-149). Additionally, we mutagenized the internal four amino acids in region 3 to alanines but again saw no effect on the V/~ stimulatory phenotype (SEA-Ala [190] [191] [192] [193] ; Table  1 ). Importantly, in all of these mutants, in contrast to the chimeras shown in Figs. 1 and 2 , we observed percentages of V/35 or VB8 equivalent to those seen in the wild-type toxins. From these data we concluded that neither region 1, 2, nor 3 alone was suf~cient to transfer V/3 specificity from one toxin to the other. It was possible that more than one region was required to transfer specificity. For example, regions 2 and 3 together may convert the V/~ stimulatory phenotype of one toxin to another.
Amino Acid Differences between SEA and SEE in the V/~-determining Domain Cluster to Four Regions.
Region 4 Alone Can Reciprocally Transfer Most of the VI~ Stimulatory Phenotype between SEA and SEE.
To investigate the possibility that the region required to transfer V/~ specificity is larger than either region 1, 2, or 3 alone, we took the approach of constructing double chimeric molecules, We started with SEA-SEE 160-161, because this is the most downstream chimera that did not show a mixed phenotype and appended the COOH terminus of SEE from amino acid 196 to the end of the molecuIe. These terminal 38 amino acids contain only six amino acid differences between SEA and SEE. Three of these amino acid differences had already been ruled out as playing a role in Vfl specificity by the chimera SEA-SEE 219-220 and the other three differences were encompassed by region 4. We were surprised to find that in these constructs, the flanking regions of the molecule dictated the Vfl specificity. For instance, SEE-SEA(161-195) was phenotypically indistinguishable from native SEE (Fig. 4) , ruling out a complex Vfl-determining site comprised of some combination of residues in regions 1-3. These chimeric molecules led us to conclude that the amino acids that determine the V/3 specificity lie downstream of amino acid 196. To test this hypothesis, we constructed the chimera SEA-SEE 195-196 as well as reciprocal region 4 exchange mutants. These mutants again demonstrated that the COOH-terminal region, specifically the three amino acid dimorphisms in region 4, dictated the Vfl specificity of these toxins. As with previous chimeras, however, reduced levels of Vfl8 and Vfl5 were now observed. The effect of these three amino acid differences on the Vfl phenotype of the toxin was especially dramatic when comparing SEA-SEE(200-207) to SEA (Fig. 4) . Mutation of these three amino acids in region 4 elevated levels of V38 and depressed Vfl5 to background levels. The phenotype of the reciprocal constructions shown in Fig. 4 demonstrated that mutation of 200-207 in SEE to the SEA sequence could also depress Vfl8 stimulation and elevate levels of VB5 (data not shown). These data demonstrate that analogous sites in SEA and SEE control stimulation of V35 and VBS, suggesting that one site on the molecule controls stimulation of all Vfls, rather than multiple TCR contact sites each controlling the stimulation of one Vfl.
All Three Amino Acid Dimorphisms in Region 4 Are Required for Complete Transfer of V~ Specificity.
To test the importance of each of the three amino acid differences in region 4, we mutated each individually. We chose to mutate the SEA molecule to the SEE sequence in these positions because, collectively, these three differences showed the most complete transfer of specificity when mutated from the SEA to the SEE sequence. Mutation of any of these amino acids individually failed to transfer specificity completely, as judged by elevation of V38 and depression of VB5 (Fig. 5) . Interestingly, each of the three individual mutations showed a distinct pattern. For the Ser--*Pro 206, V~8 levels were slightly diates VB specificity in SEA and SEE. Reciprocal exchange of region 4, containing three amino acid differences (Fig. 3) , inverted the V3 stimulatory phenotype of the toxin. Note that levels of responding V38 + T cells were not achieved unless both the NH2-and COOHterminal regions of the molecule were derived from one toxin. Responding cell popuhtions were typicaUy >97% CD3 positive with a background <0.3% positive when stained with GAM Ig FITC alone. Background staining was not subtracted. Figure 5. All three amino acid dimorphisms in region 4 are required for full transfer of V/3 specificity, Each of the three amino acid mutations alone, all contained within region 4 (see Fig. 3 ), failed to transfer specifidty from SEE to SEA as efficiently as all three together.
SEA I I
elevated above those of VBS, whereas for the Gly--~Glu 200 and Asn-~Glu 207, a reciprocal pattern was seen. This pattern was seen with T cells from all three of the individuals tested. (Fig. 4) , it was evident that sequences located upstream of amino acid 161 could complement the level of V/~8 expression from 25 to 30% of that of native SEE to full wildtype levels. To map the sequences required to complement V~8 expression to wild-type levels, we superimposed the re- Table 2 ).
NH2-terminal Residues
Discussion
We used the approach of constructing chimeric enterotoxin genes to map important functional activities on these molecules. In construction, we took advantage of the fact that the two enterotoxins most closely related structurally, SEA and SEE, differ with respect to two important immunological parameters. First, SEA stimulates human T cells that bear VB5 and not V/58, whereas SEE shows the opposite stimulatory phenotype (23) . Second, SEA binds class II with a relatively high affinity, whereas SEE binds class II molecules with an affinity so low as to be almost undetectable (24, 25) . Given these dimorphisms and their high degree of structural similarity, we assumed that chimeric molecules should re-20. (20) . Concentrations of the toxins used were 1/~g/ml for GF-purified toxins and 0.1/~g/ml for AP-purified toxins. Cells were stained with mAbs specific for the indicated V~ segment, and the blast cell population was analyzed by flow cytometry. All T cell blasts were >97% positive for CD3. Data were from one experiment.
tain these two distinct phenotypes, allowing them to be mapped genetically. This approach has several advantages. It allows one to study the enterotoxins with all functions intact, obviating the problems inherent in biochemical or genetic fragmentation of the molecule. More importantly, functions can be studied by changing them to new functions instead of knocking them out, providing a higher degree of surety that identified regions of interest are directly involved in the observed phenotypic changes. Using this approach, we identified a three-amino acid dimorphism between SEA and SEE that is responsible for the differential stimulation of human V/35 or V38 and mouse VB3 or V~11 T cells. These three amino acids are located near the COOH-terminal end of the molecule (last 15% of the linear sequence), and all three dimorphic amino acids play a role in preferential stimulation of one specific TCR VB segment versus another. Although these three amino acid differences determine most of the V3 specificity, we cannot say how many of the surrounding amino acids that are identical between the two toxins are involved in direct contact with the TCR. Thus, this area of the toxin may resemble a type of framework/complementarity-determining region arrangement in which some relatively constant residues in the toxin strengthen the interaction with the TCR, whereas other polymorphic residues may confer specificity. We can say that the upstream boundary of the site must lie distal to amino acid 195 (i.e., the end of region 3) because exchanging region 3 between SEA and SEE had no effect on the stimulatory phenotype of the two toxins. 291 Mollick et al.
In addition to mapping a V3-determining site to the COOH terminus, we used these chimeric molecules to map the region of the toxin that interacts with class II molecules to the first 70 amino acids of the NH2 terminus. These data are consistent with work from other laboratories suggesting that class II binding activity lies near the NH2 terminus. For example, using a synthetic peptide approach, Pontzer et al. (30) reported that peptides derived from the NH2 terminus block SEA binding to class II molecules. Also, Kappler et al. (18) showed that mutations located in the NH2 terminus could drastically reduce the class II binding activity of SEB. The class II binding assays (Fig. 7) also support previous reports that SEA and SEE bind class II molecules with different af~ni-ties (24) . Interestingly, we have mapped a second activity to the first 70 amino acids of SEE that when combined with the V38-specific contact site at the COOH terminus stimulated wild-type levels of V38. When this NH2-terminal site of one toxin was forced to interact with the V/3-determining region of the other, as in the chimeras, wild-type levels of appropriate Vj3-specific stimulation were not achieved. These data most likely indicate that both the NH2-and COOHterminal ends of SEA and SEE contribute to the site on the toxins that contacts the variable segment of the TCK B chain. Thus, the amino acids 200-207 might be located adjacent to NH2-terminal amino acids in the three-dimensional structure of the molecule, forming a conformational determinant that is responsible for TCR. contact and Vfl specificity. Recent studies of the crystal structure of SEB demonstrates that both NH2-and COOH-terminal ends of this superantigen are closely apposed and contribute to a shallow pocket predicted to contact the TCR (31) . Other amino acids predicted to lie in this binding site are derived from the middle part of the molecule. However, since this middle region of the protein is highly conserved between SEA and SEE, these residues, though located in the TCR binding cleft, are not the ones responsible for VB5 or Vfl8 discrimination.
Our data also support the SEB structure-function model advanced by Kappler et al. (18) . These authors reported that randomly introduced mutations localized both the class II-binding and TCR contact sites to the NH2 terminus of SEB. We have also mapped to the first 70 amino acids of SEA and SEE two activities, one that controls class II binding and a second that contributes to V/3 specificity. These data are compatible with the suggestion that the class II-binding and part of the VB-contact sites of bacterial superantigens are closely associated and perhaps intertwined in the NH2 terminus of these molecules. However, preliminary data from our laboratory indicated that this second V3 contact site in the NH2 terminus can be completely separated from the site on the molecule that determines class II binding characteristics, suggesting that the class II binding site and both Vf3 contact sites are distinct and separable on the primary structure of the molecule (J. Lamphear and R. Rich, unpublished observations).
Bacterial superantigens typically demonstrate specificity for two or more TCR V3 segments. Our data support the conclusion that these toxins contain one V3 contact site that crossreacts with several different V3s. This contrasts to a second possibility in which there may be two or more TCR contact sites on the enterotoxins, each interacting with one VB. Two human VB-stimulating activities specific for VB5 and VB8 mapped to the same region of SEA/SEE, as did stimulation of mouse VB3 and V/511. Human VB8 and mouse V~ll are ancestral homologues, whereas the human VB5 family and mouse VB3 are not related evolutionarily (32) . Thus, our data have mapped three distinct V/~ stimulatory activities to region 4 (amino acids 200-207), which suggests, but does not prove, that all VB-specific activation is controlled by this COOH-terminal region or a combination of the NH2-and COOH-terminal regions. Analysis of the VB usage by chimeric toxin-activated T cell blasts using quantitative PCR should indicate whether stimulation of all V~s are controlled by the COOH terminus or only a subset. Lastly, our model is somewhat similar to that now being proposed for MMTV-encoded endogenous superantigens. The localization of polymorphisms between the different viral superantigens suggests that the COOH terminus of these superantigens controls their VB specificity as well (33) . A broadly similar design between these two families suggests either a very old relationship and a case of divergent evolution or a striking case of convergent evolution. Our demonstration of the utility of creating chimeric superantigens to map functionally significant regions of SEA and SEE suggests that this approach may be more broadly applicable to other superantigens.
